CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tella Incorporation Company Snapshot
Tella Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tella Incorporation with three other companies in this sector in JAPAN : BrightPath Biotherapeutics Co Ltd (2019 sales of 155.81 million Japanese Yen [US$1.45 million] ), CellSeed Incorporation (275.82 million Japanese Yen [US$2.57 million] of which 58% was Cell Sheet Regenerative Medicine Busines), and Medrx Co Ltd (169.86 million Japanese Yen [US$1.58 million] of which 100% was Software Development).

Sales Analysis. Tella Incorporation reported sales of ¥202.18 million (US$1.88 million) for the year ending December of 2019. This represents a sharp decrease of 60.8% versus 2018, when the company's sales were ¥516.21 million. Contributing to the drop in overall sales was the 55.6% decline in Cell Therapy Support Business, from ¥79.02 million to ¥35.10 million. There were also decreases in sales in Cell Therapy Technology Development Busi (down 54.5% to ¥167.08 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tella Incorporation
  Stock Performance Chart for Tella Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 892.00
(Figures in Japanese Yen )
1 Week 92.7%   13 Weeks 490.7%  
4 Weeks 437.3%   52 Weeks 267.1%  
 
Tella Incorporation Key Data:
  Ticker: 2191 Country: Japan
  Exchanges: TYO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 202,182,000
(Year Ending Jan 2020).
Employees: 35
  Currency: Japanese Yen Market Cap: 20,880,652,276
  Fiscal Yr Ends: December Shares Outstanding: 23,408,803
  Share Type: Common Closely Held Shares: 2,074,823
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.